CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

To address this problem, antibody engineers introduced a serine ... gave a more homogenous monospecific product but also extended serum half-life and improved tissue distribution.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

However, because the CroFab product uses only a fragment of the cultured antibody, it causes fewer serious allergic reactions than older serum-based, whole antibody antivenoms. CroFab is a monoclonal ...